TY - JOUR
T1 - NF-κB Regulates Netrin-1 Expression and Affects the Conditional Tumor Suppressive Activity of the Netrin-1 Receptors
AU - Paradisi, Andrea
AU - Maisse, Carine
AU - Bernet, Agnès
AU - Coissieux, Marie May
AU - Maccarrone, Mauro
AU - Scoazec, Jean Yves
AU - Mehlen, Patrick
N1 - Funding Information:
Supported by institutional grants from CNRS; Centre Léon Bérard; the Ligue Contre le Cancer, INCA, ANR, STREP Hermione; and a fellowship from CNRS and ARC (to C.M.).
PY - 2008/1/1
Y1 - 2008/1/1
N2 - Background & Aims: Netrin-1 was recently proposed to play a crucial role during colorectal tumorigenesis by regulating apoptosis. Because netrin-1 receptors belong to the family of dependence receptors, a selective advantage for a tumor is either to lose netrin-1 receptors or to gain autocrine expression of netrin-1. We have investigated whether netrin-1 is up-regulated in colorectal cancer and have searched for a link between NF-κB activation and netrin-1 up-regulation. Methods: The level of netrin-1, netrin-1 receptors, ie, DCC, UNC5H1, UNC5H2, UNC5H3, and the proinflammatory markers cyclooxygenase-2 and inhibitor of nuclear factor-κB (IκB) α were analyzed in a panel of 59 primary sporadic colorectal carcinomas. Netrin-1 expression was investigated in tumor cells and in mouse colonic crypts in response to NF-κB activation but also in a mouse model of inflammation-induced colorectal cancer. Binding of NF-κB to netrin-1 promoter and effect of NF-κB activation to the proapoptotic activity of UNC5H2 were also analyzed. Results: We show that colorectal tumors with a gain of netrin-1 are tumors that display increased activation of the NF-κB pathway. Moreover, netrin-1 up-regulation, which is associated with tumor formation in mice, is observed in mouse colonic crypts in response to NF-κB activation but also in a mouse model of inflammation-induced colorectal cancer. We demonstrate that the netrin-1 gene is a direct transcriptional target of NF-κB. We show that NF-κB-induced netrin-1 expression inhibits proapoptotic activity of the netrin-1 receptors. Conclusions: We propose that NF-κB activation that occurs in response to inflammation confers a selective advantage for tumor development through NF-κB-mediated netrin-1 up-regulation.
AB - Background & Aims: Netrin-1 was recently proposed to play a crucial role during colorectal tumorigenesis by regulating apoptosis. Because netrin-1 receptors belong to the family of dependence receptors, a selective advantage for a tumor is either to lose netrin-1 receptors or to gain autocrine expression of netrin-1. We have investigated whether netrin-1 is up-regulated in colorectal cancer and have searched for a link between NF-κB activation and netrin-1 up-regulation. Methods: The level of netrin-1, netrin-1 receptors, ie, DCC, UNC5H1, UNC5H2, UNC5H3, and the proinflammatory markers cyclooxygenase-2 and inhibitor of nuclear factor-κB (IκB) α were analyzed in a panel of 59 primary sporadic colorectal carcinomas. Netrin-1 expression was investigated in tumor cells and in mouse colonic crypts in response to NF-κB activation but also in a mouse model of inflammation-induced colorectal cancer. Binding of NF-κB to netrin-1 promoter and effect of NF-κB activation to the proapoptotic activity of UNC5H2 were also analyzed. Results: We show that colorectal tumors with a gain of netrin-1 are tumors that display increased activation of the NF-κB pathway. Moreover, netrin-1 up-regulation, which is associated with tumor formation in mice, is observed in mouse colonic crypts in response to NF-κB activation but also in a mouse model of inflammation-induced colorectal cancer. We demonstrate that the netrin-1 gene is a direct transcriptional target of NF-κB. We show that NF-κB-induced netrin-1 expression inhibits proapoptotic activity of the netrin-1 receptors. Conclusions: We propose that NF-κB activation that occurs in response to inflammation confers a selective advantage for tumor development through NF-κB-mediated netrin-1 up-regulation.
UR - http://www.scopus.com/inward/record.url?scp=53249088232&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2008.06.080
DO - 10.1053/j.gastro.2008.06.080
M3 - Article
C2 - 18692059
AN - SCOPUS:53249088232
SN - 0016-5085
VL - 135
SP - 1248
EP - 1257
JO - Gastroenterology
JF - Gastroenterology
IS - 4
ER -